SU806037A1 - Антиангинальное средство - Google Patents

Антиангинальное средство Download PDF

Info

Publication number
SU806037A1
SU806037A1 SU782605039A SU2605039A SU806037A1 SU 806037 A1 SU806037 A1 SU 806037A1 SU 782605039 A SU782605039 A SU 782605039A SU 2605039 A SU2605039 A SU 2605039A SU 806037 A1 SU806037 A1 SU 806037A1
Authority
SU
USSR - Soviet Union
Prior art keywords
effect
antianginal
nitroglycerin
water
acrylamide
Prior art date
Application number
SU782605039A
Other languages
English (en)
Russian (ru)
Inventor
Эдуард Арменакович Бабаян
Галина Анатольевна Герасимова
Анатолий Борисович Давыдов
Рустам Исмаилович Утямышев
Геннадий Львович Хромов
Владимир Исаакович Метелица
Анатолий Михайлович Вихерт
Original Assignee
Всесоюзный Кардиологический Научныйцентр Amh Cccp
Всесоюзный Научно-Исследовательскийи Испытательный Институт Медицинскойтехники
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный Кардиологический Научныйцентр Amh Cccp, Всесоюзный Научно-Исследовательскийи Испытательный Институт Медицинскойтехники filed Critical Всесоюзный Кардиологический Научныйцентр Amh Cccp
Priority to SU782605039A priority Critical patent/SU806037A1/ru
Priority to CA324,996A priority patent/CA1127082A/fr
Priority to DE19792913752 priority patent/DE2913752A1/de
Priority to FR7908827A priority patent/FR2421610A1/fr
Priority to GB7912104A priority patent/GB2021610B/en
Priority to JP54041172A priority patent/JPS6024763B2/ja
Priority to GB8120761A priority patent/GB2078771B/en
Application granted granted Critical
Publication of SU806037A1 publication Critical patent/SU806037A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU782605039A 1978-04-06 1978-04-06 Антиангинальное средство SU806037A1 (ru)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SU782605039A SU806037A1 (ru) 1978-04-06 1978-04-06 Антиангинальное средство
CA324,996A CA1127082A (fr) 1978-04-06 1979-04-05 Film pour traiter l'angine de poitrine et les ischemies cardiaques
DE19792913752 DE2913752A1 (de) 1978-04-06 1979-04-05 Arzneifilm mit antianginaler wirkung
FR7908827A FR2421610A1 (fr) 1978-04-06 1979-04-06 Pellicule medicamenteuse a base d'une substance active a action anti angineuse telle que la nitroglycerine ou l'isosorbide dimitrate
GB7912104A GB2021610B (en) 1978-04-06 1979-04-06 Antianginal composition
JP54041172A JPS6024763B2 (ja) 1978-04-06 1979-04-06 抗アンギ−ナフィルム
GB8120761A GB2078771B (en) 1978-04-06 1979-04-06 Drug carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU782605039A SU806037A1 (ru) 1978-04-06 1978-04-06 Антиангинальное средство

Publications (1)

Publication Number Publication Date
SU806037A1 true SU806037A1 (ru) 1981-02-23

Family

ID=20759951

Family Applications (1)

Application Number Title Priority Date Filing Date
SU782605039A SU806037A1 (ru) 1978-04-06 1978-04-06 Антиангинальное средство

Country Status (6)

Country Link
JP (1) JPS6024763B2 (fr)
CA (1) CA1127082A (fr)
DE (1) DE2913752A1 (fr)
FR (1) FR2421610A1 (fr)
GB (2) GB2021610B (fr)
SU (1) SU806037A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529589A (en) * 1981-07-14 1985-07-16 Davydov Anatoly B Pharmaceutical composition for the treatment of diabetes mellitus

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
CA1218604A (fr) * 1981-07-08 1987-03-03 Alec D. Keith Vehicules de trinitroglycerol a decharge temporisee, et leurs domaines d'emploi
AU553343B2 (en) * 1981-08-10 1986-07-10 Advance Electrode Kabushikikaisya Absorbent adhesive bandage with medicament release
US4482533A (en) * 1982-01-11 1984-11-13 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing propranolol
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
FR2542998B1 (fr) * 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
US4693887A (en) * 1983-09-15 1987-09-15 The Kendall Company Microphase separated hydrogels for controlled release of bioactive materials
JPS6066759A (ja) * 1983-09-21 1985-04-16 日東電工株式会社 医薬製剤
JPS60148471A (ja) * 1983-12-27 1985-08-05 マンヴイル　サービス　コーポレーション 王冠支持式キヤリヤ
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3823395A1 (de) * 1988-07-09 1990-03-15 Holzapfel Boeving Partner Werb Mit einem wirkstoff getraenktes tuch
EP0409383B1 (fr) * 1989-07-21 1994-04-06 Izhak Blank Compositions à base d'estradiol et procédés d'application topique
US5232703A (en) * 1989-07-21 1993-08-03 Izhak Blank Estradiol compositions and methods for topical application
US5204109A (en) * 1989-12-28 1993-04-20 Nitto Denko Corporation Percutaneous gel preparation
CA2611418C (fr) * 2005-06-08 2010-10-05 Basf Corporation Composition de porteur de medicament du procede de formation de film de la partir de cette composition
RU2015105097A (ru) * 2012-08-23 2016-10-10 Кардиолинкс Аг Композиции аминоалкилнитрата с пролонгированным высвобождением

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE859931C (de) * 1944-05-24 1952-12-18 Roehm & Haas G M B H Galenische Praeparate
DE2301664C3 (de) * 1973-01-13 1979-07-12 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral verabreichbares, Nitroglycerin enthaltendes Arzneimittel
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
ZA765931B (en) * 1975-10-10 1977-09-28 Squibb & Sons Inc Controlled release tablet
DE2634004B2 (de) * 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529589A (en) * 1981-07-14 1985-07-16 Davydov Anatoly B Pharmaceutical composition for the treatment of diabetes mellitus

Also Published As

Publication number Publication date
GB2078771A (en) 1982-01-13
FR2421610A1 (fr) 1979-11-02
JPS54154511A (en) 1979-12-05
GB2021610B (en) 1982-10-20
JPS6024763B2 (ja) 1985-06-14
CA1127082A (fr) 1982-07-06
DE2913752A1 (de) 1979-12-20
GB2078771B (en) 1983-03-09
FR2421610B1 (fr) 1982-11-12
GB2021610A (en) 1979-12-05

Similar Documents

Publication Publication Date Title
SU806037A1 (ru) Антиангинальное средство
US4292301A (en) Polymeric diffusion matrix containing ephedrine
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
BE901994A (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
NO934523D0 (no) Fremgangsmaate for justering av metningskonsentrasjonen av et legemiddel for transde mal adminstrasjon
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
RU94035739A (ru) Фармацевтическая композиция, содержащая нифедипин, и способ ее получения
US8003696B2 (en) Composition and method for treating bacterial, viral, fungal diseases, inflammation and pain
FR2464714A1 (fr) Composition pharmaceutique topique contenant de la triethylenetetramine
JPS6242973A (ja) Ｌ−リジンピルベ−ト及びｌ−ヒスチジンピルベ−ト
CN1195524A (zh) 药物制剂
FR2676363A1 (fr) Antidote prophylactique contre les poisons organophosphoriques.
US4857313A (en) Transdermal drug delivery device comprising copolymers of N-morpholinoethyl methacrylate and 2-hydroxylmethacrylate
JPH02501982A (ja) 医薬製剤の経皮的投与のためのポリマー性拡散マトリックスの組成物
EP2910254B1 (fr) Base et préparation externe pour la peau
JPS635378B2 (fr)
CA2259584A1 (fr) Patchs contenant du dinitrate d'isosorbide
FR2522968A1 (fr) Medicament cytotoxique forme de l'association d'a u moins une immunotoxine et de la chloroquine
US4006223A (en) Drug composition intended for the treatment of acute, lethal and chronic radiation disease
FR2536997A1 (fr) Medicaments cytotoxiques comportant au moins une immunotoxine et de la methylamine
BE1004857A3 (fr) Complexes de l'acide polyadenylique avec l'acide polyuridylique.
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
FR2584604A1 (fr) Composition therapeutique constituant une nouvelle forme galenique orale pour ameliorer la cinetique de la biodisponibilite
RU2280438C2 (ru) Средство "форидон-гель" для лечения и профилактики сердечно-сосудистых заболеваний
KR100334372B1 (ko) 원치않는진통작용을억제하고,조산을억제하고,진통작용을조절하기위한경피투여용의약품